The session will explore the factors driving higher global patent prosecution costs, including foreign filing, translation, local-agent fees, office action practice, validations, and renewals. Panelists will share practical approaches to budgeting, vendor management, workflow standardization, and controlling costs while maintaining strong patent protection.

Bryan counsels innovators in the chemical, biotechnology, pharmaceutical, medical device, and healthcare industries on domestic and international patent strategy. He advises clients ranging from startups and academic institutions to venture-backed companies and global corporations on patent procurement, portfolio management, due diligence, licensing, freedom-to-operate analyses, and intellectual property transactions. 

Joining Bryan on the panel are Joseph Sherinsky, Assistant General Counsel, Litigation & IP, Mitsubishi Chemical America, Inc., and William Schmidt, IP Counsel, Beam Therapeutics. The discussion will be moderated by Kim Whitehead, Senior Director, Business Strategy, TransPerfect IP.